Ampio Pharmaceuticals Inc. (AMPE) stock fell during pre-market trading. Here’s to know why?
Ampio Pharmaceuticals Inc. (NASDAQ: AMPE) stock gained by 4.71% at last close whereas the AMPE stock price declines by 2.65% in the pre-market trading session. AMPE has acquired regulatory clearance to expand the AP-019 Phase II study’s enrolment to India. The research will use inhaled Ampion to treat those who have COVID-19-related respiratory distress. What […]
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) shares up in the sky after this update
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) stock soared 17.36% to $1.42 in the pre-market trading session following an announcement by a biopharmaceutical corporation focusing on advancing immunology-based treatments for common inflammatory disorders that two collaboration have been reached to explore potential therapeutic applications for its immunomodulatory drug, Ampion. The Organization has entered into a cooperative […]
